Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Rasagiline mesylate microsphere preparation and preparation method thereof

A technology of rasagiline mesylate and microspheres, which can be used in pharmaceutical formulations, medical preparations containing no active ingredients, and medical preparations containing active ingredients, etc. To solve problems such as poor stability of colostrum, achieve the effect of reducing initial release, increasing stability, and increasing viscosity

Active Publication Date: 2021-01-08
CHINA PHARM UNIV
View PDF4 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

For example, the drug tends to be distributed on the surface of the microspheres, resulting in a higher initial drug release, which increases the risk of side effects; the poor stability of the prepared colostrum will significantly increase the batch-to-batch variation in the microsphere preparation process, although the researchers Attempts to improve the stability of colostrum through various methods (such as adding surfactants, reducing the density difference between oil and water, etc.), but still have little effect

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Rasagiline mesylate microsphere preparation and preparation method thereof
  • Rasagiline mesylate microsphere preparation and preparation method thereof
  • Rasagiline mesylate microsphere preparation and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] Dissolve 15 mg of rasagiline mesylate in 0.3 mL of 5% tannic acid solution to obtain an inner aqueous phase. 270 mg of PLGA (50 / 50, 0.36 dl / g, carboxyl-terminated) was dissolved in 3 ml of dichloromethane to obtain an oily phase. Under 12000rpm, the inner water phase and the oil phase were shear mixed to obtain the primary emulsion. Add the primary emulsion to the continuous external aqueous phase containing 0.8% sodium chloride and 1% PVA through a peristaltic pump, and homogeneously emulsify for 10 minutes under stirring at 900 rpm to form double emulsion. Subsequently, the stirring speed was reduced to 300 rpm for 6 hours, and the organic solvent was volatilized and removed. The microspheres were collected by filtration, washed three times with deionized water, and freeze-dried to obtain microsphere powder.

Embodiment 2

[0031] The microsphere preparation steps and basic prescription composition of this example are the same as those in Example 1, but the mass percent concentration of the tannic acid solution that dissolves the drug to form the inner water phase is 2%.

Embodiment 3

[0033] The microsphere preparation steps and basic prescription composition of this example are the same as Example 1, but the mass percent concentration of the tannic acid solution that dissolves the drug to form the inner water phase is 1%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a rasagiline sustained-release microsphere preparation. The rasagiline sustained-release microsphere preparation contains rasagiline mesylate, a lactide-glycolide copolymer anda release regulator. The invention also discloses rasagiline mesylate microspheres prepared by adopting a multiple emulsion solvent evaporation method. A proper amount of release regulator is added into an inner water phase, so that the burst release amount of the drug-loaded microspheres can be remarkably reduced; the stability of the colostrum is improved, and the inter-batch difference causedby poor stability of the colostrum can be avoided; and the micromorphology of the drug-loaded microspheres is improved. The drug-loaded microspheres prepared by the improved method have high encapsulation efficiency and low burst release amount, and can realize uniform and slow release of drugs.

Description

technical field [0001] The invention relates to pharmaceutical preparations, in particular to rasagiline mesylate microspheres and a preparation method thereof. Background technique [0002] Parkinson's disease is a primary chronic progressive movement disorder that mostly affects the elderly. The prevalence of Parkinson's disease among people over 65 years old in my country is about 1.7%, and most Parkinson's patients are sporadic cases. The pathogenesis of Parkinson's is the lesion or necrosis of dopaminergic neurons in the central nigrostriatal pathway, resulting in a reduction or absence of dopamine in the striatum. The first symptom of Parkinson's disease is usually a tremor or clumsiness in one limb that then spreads to the other limb. The main clinical manifestations are bradykinesia, resting tremor, posture and gait disorder, and muscle rigidity. In severe cases, it is accompanied by mental impairment such as memory impairment and dementia, which seriously affects ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/16A61K9/19A61K31/135A61K47/34A61P25/16
CPCA61K31/135A61K9/19A61K9/1647A61P25/16Y02A50/30
Inventor 周卫李乐刘正魏悦蕾蔡青纯
Owner CHINA PHARM UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products